The cost-effectiveness of treatments for male infertility

References

• Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet340(8810), 17–18 (1992).
   PubMed Web of Science ®Google Scholar
• Clermont Y, Heller C. Spermatogenesis in man: an estimate of its duration. Science (140), 184–185 (1963).
   PubMedGoogle Scholar
• Franca LR, Avelar GF, Almeida FFL. Spermatogenesis and sperm transit through the epididymis with emphasis on pigs. Theriogenology (63), 300–318 (2005).
   PubMedGoogle Scholar
• Misell LM, Holochwost D, Boban D et al. A stable isotope/mass spectrometric method for measuring the kinetics of human spermatogenesis in vivo. J. Urol. (175), 242–246 (2006).
   PubMedGoogle Scholar
• Turek P. Practical approaches to the diagnosis and management of male infertility. Nat. Clin. Pract. Urol.2(5), 226–238 (2005).
   PubMedGoogle Scholar
• Schiff J, Ramirez M, Bar-Chama N. Medical and surgical management male infertility. Endocrinol. Metab. Clin. N. Am.36(2), 313–331 (2007).
   PubMed Web of Science ®Google Scholar
• Lui P, Handelsman D. The present and future state of hormonal treatment for male infertility. Hum. Reprod. Update9(1), 9–23 (2003).
   PubMedGoogle Scholar
• Haidl G. Management strategies for male factor infertility. Drugs62(12), 1741–1753 (2002).
   PubMed Web of Science ®Google Scholar
• Haidl G, Schill WB. Guidelines for drug treatment of male infertility. Drugs41(1), 60–68 (1991).
   PubMedGoogle Scholar
• Sigman M, Jarow JP. Endocrine evaluation of infertile men. Urology50(5), 659–664 (1997).
   PubMed Web of Science ®Google Scholar
• Burris AS, Clark RV, Vantman DJ, Sherins RJ. A low sperm concentration does not preclude fertility in men with isolated hypogondatropic hypogonadism after gonadotropin therapy. Fertil. Steril.50(2), 343–347 (1988).
   PubMed Web of Science ®Google Scholar
• Caroppo E, Niederberger C, Vizziello GM, D’Amato G. Use of recombinant follicle stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoosperic patients undergoing intracytoplasmic sperm injection. Fertil. Steril.80(6), 1398–1406 (2003).
   PubMedGoogle Scholar
• Ashkenazi J, Bar-Hava I, Farhi J et al. The role of purified follicle stimulating hormone therapy in the make partner before intracytoplasmic sperm injection. Fertil. Steril.72(4), 670–673 (1999).
   PubMed Web of Science ®Google Scholar
• Attia AM, Al-Inany HG, Farquhar C, Proctor M. Gonadotropins for idiopathic male factor subfertility. Cochrane Database Syst. Rev.4, CD005071 (2007).
   Google Scholar
• World Health Organization. A double blind study trail of clomiphene citrate for the treatment of idiopathic male infertility. Int. J. Androl.15(4), 299–307 (1992).
   PubMedGoogle Scholar
• Vandekerckhove P, Lilford R, Vail A, Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst. Rev.4, CD000151 (1996).
   Google Scholar
• Whitten SJ, Nangia AK, Kolettis PN. Select patients with hypogonadotropic hypogonadism may respond to treatment with clomiphene citrate. Fertil. Steril.86(6), 1664–1668 (2006).
   PubMed Web of Science ®Google Scholar
• Kamischke A, Nieschlag E. Analysis of medical treatment of male infertility. Hum. Reprod.14(Suppl. 1), 1–23 (1999).
   PubMed Web of Science ®Google Scholar
• Köhn FM, Erdmann I, Oeda T, el Mulla KF, Schiefer HG, Schill WB. Influence of urogenital infections on sperm functions. Andrologia30(Suppl. 1), 73–80 (1998).
   PubMedGoogle Scholar
• Rose BI, Scott B. Sperm motility, morphology, hyperactivation, and ionophore-induced acrosome reactions after overnight incubation with mycoplasmas. Fertil. Steril.61(2), 341–348 (1994).
   PubMed Web of Science ®Google Scholar
• Diemer T, Ludwig M, Huwe P, Hales DB, Weidner W. Influence of urogenital infection on sperm function. Curr. Opin. Urol.10(1), 39–44 (2000).
   PubMedGoogle Scholar
• Diemer T, Weidner W, Michelmann HW, Schiefer HG, Rovan E, Mayer F. Influence of Escherichia coli on motility parameters of human spermatozoa In vitro. Int. J. Androl.19(5), 271–277 (1996).
   PubMed Web of Science ®Google Scholar
• Núñez-Calonge R, Caballero P, Redondo C, Baquero F, Martínez-Ferrer M, Meseguer MA. Ureaplasma urealyticum reduces motility and induces membrane alterations in human spermatozoa. Hum. Reprod.13(10), 2756–2761 (1998).
   PubMed Web of Science ®Google Scholar
• Kessopoulou E, Powers HJ, Sharma KK et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil. Steril.64(4), 825–831 (1995).
   PubMed Web of Science ®Google Scholar
• Geva E, Bartoov B, Zabludovsky N, Lessing JB, Lerner-Geva L, Amit A. The effect of antioxidant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil. Steril.66(3), 430–434 (1996).
   PubMed Web of Science ®Google Scholar
• Greco E, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, Tesarik J. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J. Androl.26(3), 349–353 (2005).
   PubMed Web of Science ®Google Scholar
• Song GJ, Norkus EP, Lewis V. Relationship between seminal ascorbic acid and sperm DNA integrity in infertile men. Int. J. Androl.29(6), 569–575 (2006).
   PubMedGoogle Scholar
• Kumar TR, Wiseman AL, Kala G, Kala SV, Matzuk MM, Lieberman MW. Reproductive defects in γ-glutamyl transpeptidase-deficient mice. Endocrinology141(11), 4270–4277 (2000).
   PubMed Web of Science ®Google Scholar
• Comhaire FH, Christophe AB, Zalata AA, Dhooge WS, Mahmoud AM, Depuydt CE. The effects of combine conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot. Essent. Fatty Acids63(3), 159–165 (2000).
   PubMed Web of Science ®Google Scholar
• Lenzi A, Picardo M, Gandini L, Dondero F. Lipids of sperm plasma membrane: from polyunsaturated fatty acid considered as markers of sperm function to possible scavenger therapy. Hum. Reprod. Update (2), 246–256 (1996).
   PubMedGoogle Scholar
• Lenzi A, Gandini L, Lombardo F et al. Polyunsaturated fatty-acids of germ cell membranes, glutathione and blutathione-dependent enzyme-PHGPx: from basic to clinic. Contraception (65), 301–304 (2002).
   PubMedGoogle Scholar
• Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA, Steegers-Theunissen RP. Effects of folic acid and zinc sulfate on male factor subfertility: a double blind, randomized, placebo-controlled trial. Fertil. Steril.77(3), 491–498 (2002).
   PubMed Web of Science ®Google Scholar
• Prasad AS. Discovery of human zinc deficiency and studies in an experimental human model. Am. J. Clin. Nutr. (53), 403–412 (1991).
   PubMedGoogle Scholar
• Netter A, Hartoma R, Nahoul K. Effect of zinc administration on plasma testosterone, dihydrotestosterone, and sperm count. Arch. Andr.7(1), 69–73 (1981).
   PubMed Web of Science ®Google Scholar
• Abbasi AA, Prasad AS, Rabbani P, DuMouchelle E. Experimental zinc deficiency in man. Effect on testicular function. J. Lab. Clin. Med. (96), 544–550 (1980).
   PubMedGoogle Scholar
• Lenzi A, Lombardo F, Sgrò P et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind cross over trial. Fertil. Steril.79(2), 292–300 (2003).
   PubMed Web of Science ®Google Scholar
• Lenzi A, Sgrò P, Salacone P et al. A placebo-controlled double-blind randomized trial of the use of combined L-carnitine and L-acetyl-carnitine treatment in men with asthenozoospermia. Fertil. Steril.81(6), 1578–1584 (2004).
   PubMed Web of Science ®Google Scholar
• Evers JL, Collins JA, Vandekerckhove P. Surgery or embolisation for varicocele in subfertile men. Cochrane Database Syst. Rev.1, CD000479 (2001).
   Google Scholar
• Cayan S, Erdemir F, Ozbey I, Turek PJ, Kadiolu A, Tellalolu S. Can varicocelectomy significantly change the way couples use assisted reproductive technologies? J. Urol.167(4), 1749–1752 (2002).
   PubMed Web of Science ®Google Scholar
• Purohit RS, Wu DS, Shinohara K, Turek PJ. A prospective comparison of 3 diagnostic methods to evaluate ejaculatory duct obstruction. J. Urol.171(1), 232–236 (2004).
   PubMedGoogle Scholar
• Turek PJ, Magana JO, Lipshultz LI. Semen parameters before and after transurethral surgery for ejaculatory duct obstruction. J. Urol.155(4), 1291–1293 (1996).
   PubMedGoogle Scholar
• Sharlip ID. What is the best pregnancy rate that may be expected from vasectomy reversal? J. Urol. (149), 1469–1471 (1993).
   PubMedGoogle Scholar
• Temple-Smith PD, Southwick GJ, Yates CA, Trounson AO, de Kretser DM. Human pregnancy by In vitro fertilization (IVF) using sperm aspirated from the epididymis. J. In vitro Fert. Embryo Transf.2(3), 119–122 (1985).
   PubMedGoogle Scholar
• Goldstein M, Tanrikut C. Microsurgical management of male infertility. Nat. Clin. Pract. Urol.3(7), 381–391 (2006).
   PubMedGoogle Scholar
• Van Peperstraten A, Proctor ML, Johnson NP, Philipson G. Techniques for surgical retrieval of sperm prior to ICSI for azoospermia. Cochrane Database Syst. Rev.3, CD002807 (2006).
   Google Scholar
• Donoso P, Tournaye H, Devroey P. Which is the best sperm retrieval technique for non-obstructive azoospermia? A systematic review. Hum. Reprod. Update (13), 539–549 (2007).
   PubMedGoogle Scholar
• Jarow JP, Sharlip ID, Belker AM et al. Male Infertility Best Practice Policy Committee of the American Urological Association Inc. Best practice policies for male infertility. J. Urol.167(5), 2138–2144 (2002).
   PubMed Web of Science ®Google Scholar
• Schlegel PN. Is assisted reproduction the optimal treatment for varicocele-associated male infertility? A cost-effectiveness analysis. Urology49(1), 83–90 (1997).
   PubMedGoogle Scholar
• Penson D, Paltiel A, Krumholz H, Palter S. The cost-effectiveness of treatment for varicocele related infertility. J. Urol.168(6), 2490–2494 (2002).
   PubMed Web of Science ®Google Scholar
• Meng M, Greene K, Turek P. Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility. J. Urol.174(5), 1926–1931 (2005).
   PubMed Web of Science ®Google Scholar
• Kolettis PN, Thomas AJ Jr. Vasoepididymostomy for vasectomy reversal: a critical assessment in the era of intracytoplasmic sperm injection. J. Urol.158(2), 467–470 (1997).
   PubMed Web of Science ®Google Scholar
• Pavlovich CP, Schlegel PN. Fertility options after vasectomy: a cost–effectiveness analysis. Fertil. Steril.67(1), 133–141 (1997).
   PubMed Web of Science ®Google Scholar
• Heidenreich A, Altmann P, Engelmann UH. Microsurgical vasavasostomy versus microsurgical epididymal sperm aspiration/testicular extraction of sperm combined with intracytoplasmic sperm injection. A cost benefit analysis. Eur. Urol.37(5), 609–614 (2000).
   PubMed Web of Science ®Google Scholar
• Pasqualotto F, Lucon A, Sobreiro B, Pasqualotto E, Arap S. The best infertility treatment for vasectomized men, assisted reproduction or vasectomy reversal? Rev. Hosp. Clin. Fac. Med. S. Paulo59(5), 312–315 (2004).
   PubMedGoogle Scholar
• Hsieh MH, Meng MV, Turek PJ. Markov modeling of vasectomy reversal and ART for infertility: how do obstructive interval and female partner age influence cost effectiveness? Fertil. Steril.88(4), 840–846 (2007).
   PubMedGoogle Scholar
• Nieschlag E, Hertle L, Fischedick A et al. Update on treatment of varicocele: counseling as effective as occlusion of the vena spermatica. Hum. Reprod.13, 2147–2150 (1998).
   PubMed Web of Science ®Google Scholar
• Madgar I, Korasik A, Weissenberg R et al. Controlled trial of high spermatic vein ligation for varicocele in infertile men. Fert. Ster.63, 120–124 (1995).
   PubMed Web of Science ®Google Scholar